eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | rheumatoid arthritis |
| Comorbidity | C0004153|atherosclerosis |
| Sentences | 53 |
| PubMedID- 25716931 | Subclinical atherosclerosis in patients with rheumatoid arthritis. |
| PubMedID- 21885483 | Serum hepcidin: a direct link between anemia of inflammation and coronary artery atherosclerosis in patients with rheumatoid arthritis. |
| PubMedID- 26504820 | This prospective study of an inception cohort aimed to investigate whether the level of lp-pla2 is associated with subclinical atherosclerosis in patients with rheumatoid arthritis (ra). |
| PubMedID- 23273674 | Carotid atherosclerosis in patients with rheumatoid arthritis and rheumatoid nodules. |
| PubMedID- 26122966 | Prevalence of atherosclerosis in patients with inactive rheumatoid arthritis. |
| PubMedID- 25772817 | Vascular abnormalities predisposing to atherosclerosis are present in patients with rheumatoid arthritis (ra) and associate with excess cardiovascular risk. |
| PubMedID- 25366205 | Subclinical atherosclerosis in patients with rheumatoid arthritis by utilizing carotid intima-media thickness as a surrogate marker. |
| PubMedID- 24507828 | Response to 'adipokines, inflammation, insulin resistance, and carotid atherosclerosis in patients with rheumatoid arthritis'. |
| PubMedID- 22364135 | The effect of anti-b-cell therapy on the development of atherosclerosis in patients with rheumatoid arthritis. |
| PubMedID- 22899879 | To determine whether treatment with the anti-tnf-alpha blocker adalimumab yields persistent improvement of endothelial function and prevents from morphological progression of subclinical atherosclerosis in patients with rheumatoid arthritis (ra) refractory to conventional therapy, a series of 34 consecutive ra patients, attending hospital outpatient clinics and who were switched from disease modifying antirheumatic drug therapy to anti-tnf-alpha-adalimumab treatment because of severe disease, were assessed by ultrasonography techniques before the onset of adalimumab therapy (at day 0) and then at day 14 and at month 12. |
| PubMedID- 24713330 | Interestingly, situations like this in diabetes mellitus have also been found in chronic inflammatory rheumatic diseases such as rheumatoid arthritis; a disease associated with accelerated atherosclerosis with an increased risk of cardiovascular death similar to diabetes mellitus [9]. |
| PubMedID- 20516025 | Lipoprotein subclasses determined by nuclear magnetic resonance spectroscopy and coronary atherosclerosis in patients with rheumatoid arthritis. |
| PubMedID- 22340996 | Objective: despite the recognized risk of accelerated atherosclerosis in patients with rheumatoid arthritis (ra), little is known about cardiovascular risk management in contemporary cohorts of these patients. |
| PubMedID- 25777147 | Can the ankle brachial pressure index (abpi) and carotis intima media thickness (cimt) be new early stage markers of subclinical atherosclerosis in patients with rheumatoid arthritis. |
| PubMedID- 22053612 | Subclinical atherosclerosis is increased in patients with rheumatoid arthritis (ra), as chronic systemic inflammation leads to accelerate atherosclerosis and increase arterial stiffness in theses patients. |
| PubMedID- 21420089 | Objective: to assess the influence of the tnfa rs1800629 (g > a) polymorphism in the risk of cardiovascular (cv) disease and subclinical atherosclerosis in patients with rheumatoid arthritis (ra). |
| PubMedID- 21281743 | While classical accelerated atherosclerosis has been associated with rheumatoid arthritis (ra), systemic lupus erythematosus (sle) or spondyloarthropathies (spa), obliterative vasculopathy may rather be characteristic for systemic sclerosis (ssc) or mixed connective tissue disease (mctd). |
| PubMedID- 20346241 | Objectives: to assess whether the polymorphism of the macrophage migration inhibitory factor (mif) gene at the position -173 is implicated in the disease susceptibility, risk of cardiovascular (cv) events and presence of subclinical atherosclerosis in patients with rheumatoid arthritis (ra). |
| PubMedID- 23125485 | atherosclerosis in rheumatoid arthritis. |
| PubMedID- 20337633 | rheumatoid arthritis (ra) is associated with enhanced atherosclerosis and impaired endothelial function early after the onset of the disease and cardiovascular (cv) disease represents one of the leading causes of morbidity and mortality. |
| PubMedID- 20197564 | Accelerated atherosclerosis in rheumatoid arthritis: rationale for mannose-binding lectins. |
| PubMedID- 23020882 | Mechanisms of premature atherosclerosis in rheumatoid arthritis and lupus. |
| PubMedID- 23025038 | Carotid ultrasound as predictor of atherosclerosis in rheumatoid arthritis. |
| PubMedID- 24488413 | Independent relationship of osteoprotegerin concentrations with endothelial activation and carotid atherosclerosis in patients with severe rheumatoid arthritis. |
| PubMedID- 24286380 | Progression of coronary artery atherosclerosis in rheumatoid arthritis: comparison with participants from the multi-ethnic study of atherosclerosis. |
| PubMedID- 21490773 | Inflammatory processes in rheumatoid arthritis lead to accelerated atherosclerosis and afflicted patients have an elevated risk for cardiovascular events leading to a higher mortality [1]. |
| PubMedID- 22000818 | Objectives: rheumatoid arthritis (ra) is associated with premature atherosclerosis and increased prevalence of cardiovascular disease. |
| PubMedID- 24833785 | Investigation of a pon1 gene polymorphism (rs662 polymorphism) as predictor of subclinical atherosclerosis in patients with rheumatoid arthritis. |
| PubMedID- 26247590 | Subclinical atherosclerosis in patients with rheumatoid arthritis and low cardiovascular risk: the role of von willebrand factor activity. |
| PubMedID- 20553683 | Objective: rheumatoid arthritis (ra) is associated with accelerated atherosclerosis in the carotid arteries, but little is known about the magnitude of this process in peripheral arteries. |
| PubMedID- 24245495 | Adipokines, inflammation, insulin resistance, and carotid atherosclerosis in patients with rheumatoid arthritis. |
| PubMedID- 25679449 | A variant in the osteoprotegerin gene is associated with coronary atherosclerosis in patients with rheumatoid arthritis: results from a candidate gene study. |
| PubMedID- 26571131 | Objectives: to determine whether the interleukin-33 (il-33)-interleukin-1 receptor like 1 (il-1rl1) signaling pathway is implicated in the risk of subclinical atherosclerosis in patients with rheumatoid arthritis (ra). |
| PubMedID- 21846359 | Introduction: the aim of our study was to analyze the influence of the ccr5delta32 polymorphism in the risk of cardiovascular (cv) events and subclinical atherosclerosis among patients with rheumatoid arthritis (ra). |
| PubMedID- 25956924 | We hypothesized that glyca is a biomarker of disease activity and is associated with coronary artery atherosclerosis in patients with rheumatoid arthritis (ra). |
| PubMedID- 21165753 | Therefore, the aim of the study was to determine serum visfatin level and its association with common carotid intima-media thickness (imt), which is a predictor of atherosclerosis, in patients with rheumatoid arthritis (ra), systemic lupus erythematosus (sle), systemic sclerosis (ssc), and behcet's disease (bd). |
| PubMedID- 20360191 | atherosclerosis in rheumatoid arthritis: what to look for in studies using carotid ultrasound. |
| PubMedID- 21239756 | Objective: studies indicate that ankylosing spondylitis (as), as well as rheumatoid arthritis, may be associated with accelerated atherosclerosis and vascular disease. |
| PubMedID- 20197563 | Coronary atherosclerosis in rheumatoid arthritis: could endothelial progenitor cells be the missing link. |
| PubMedID- 21780652 | Aim: to study the role of conventional and new factors of cardiovascular risk in development of atherosclerosis in patients with rheumatoid arthritis (ra) and psoriatic arthritis (pa). |
| PubMedID- 22673743 | Endothelial dysfunction leads to accelerated atherosclerosis in rheumatoid arthritis, systemic lupus erythematosus and spondyloarthropaties whereas obliterative vasculopathy is associated with systemic sclerosis. |
| PubMedID- 21345288 | Objectives: to assess the influence of the retn rs1862513 polymorphism in the risk of cardiovascular (cv) disease and subclinical atherosclerosis in patients with rheumatoid arthritis (ra). |
| PubMedID- 23852762 | Cardiovascular risk stratification in rheumatic diseases: carotid ultrasound is more sensitive than coronary artery calcification score to detect subclinical atherosclerosis in patients with rheumatoid arthritis. |
| PubMedID- 21473861 | Increased serum levels of beta(2)-gpi-lp(a) complexes and their association with premature atherosclerosis in patients with rheumatoid arthritis. |
| PubMedID- 22915532 | Predictors of atherosclerosis in rheumatoid arthritis. |
| PubMedID- 25825281 | atherosclerosis in rheumatoid arthritis: is it all about inflammation. |
| PubMedID- 24878796 | Background: atherosclerosis in rheumatoid arthritis (ra) patients may be aggravated by obesity. |
| PubMedID- 21696620 | Correlation between endothelial function and carotid atherosclerosis in rheumatoid arthritis patients with long-standing disease. |
| PubMedID- 22830205 | Aim: to evaluate tocilizumab (tlz) effects on blood lipids composition and severity of carotid arteries (ca) atherosclerosis in rheumatoid arthritis (ra) patients after 24 week tlz treatment. |
| PubMedID- 23295110 | Objectives: rheumatoid arthritis (ra) is associated with accelerated atherosclerosis and premature cardiovascular death. |
Page: 1 2